Fri, Jul 25, 2014, 2:29 PM EDT - U.S. Markets close in 1 hr 31 mins

Recent

% | $
Click the to save as a favorite.

Taro Pharmaceutical Industries Ltd. Message Board

  • imho_dyodd imho_dyodd Aug 26, 2013 8:34 AM Flag

    1 Tidbit has been inadvertently left in the last friday filing

    While they tout the 2 directors and their contribution towards share price of $65, what seems to be "inadvertently" omitted is these 2 directors recommended us to vote in favor of $39.5 offer on 10/05/2012.

    It would have been fair and balanced if they had indicated this little nugget of information.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Board,

      Where is Accountability in your ISS presentation/recommendation of these incumbent external directors ??

      Was this stock price at $65 a surprise ? Not at all. In our opinion, these directors FAILED to perform their duty towards ALL shareholders when they recommended $39.5 on 10/05/2012 stating this is the best option for shareholders. They already knew for the 1st 6 months the estimates were way off...yet those estimates and low multiple was used to justify the offer.

      Even at today's $65 Valuation multiples taro is still very cheap compared to peers.

      Can you please embrace all shareholders as your own ? Or pay fair valuation multiples (15-20 times EBITDA). Look at Agila Specialties which was sold for 18.6 times EBITDA not contingent payments. The dermatology generic sector is an oligopoly for a long time due to fundamental reasons that is publicly known. It clearly deserves comparable multiple.

      Please embrace minority shareholders as your own and withdraw your incumbent directors. They have FAILED to perform their duty towards ALL shareholders in our opinion.

      Please act in GOOD FAITH. It is a request from one shareholder.

 
TARO
143.70-1.01(-0.70%)2:29 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.